12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Deals

Pfizer, Takeda deal

Pfizer granted Takeda rights to co-market tofacitinib (formerly tasocitinib) in Japan for rheumatoid arthritis and other undisclosed...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >